- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Medical Management Of Placenta Accreta In A Primipara Following Vaginal Delivery |
| Country | : | India |
| Authors | : | Dr Anubha Singh Chandel |
![]() |
: | 10.9790/0853-2501040103 ![]() |
Abstract: The incidence of placenta accreta, a potentially life-threatening obstetric condition has increased over the years. Women at greatest risk of placenta accreta are those who have myometrial damage caused by a previous cesarean delivery. Morbidly adherent placenta in the absence of risk factors is a rare entity in primigravida, and its conservative......
Key Word: Placenta accreta, Medical management, Methotrexate.
[1]. Valentin Nicolae Varlas, Roxana Georgiana Bors , Simona Birsanu , Bogdan Maxim , Eliza Clotea , Maria Mihailov. Maternal And Fetal Outcome In Placenta Accreta Spectrum (PAS) Associated With Placenta Previa: A Retrospective Analysis From A Tertiary Center .2021 May-Jun;14(3):367-375.Doi: 10.25122/Jml-2021-0134.
[2].
Hsiu-Wei Su , Yu-Chiao Yi , Jenn-Jhy Tseng , Wei-Chih Chen , Ya-Fang Chen , Hsiao-Fan Kung , Min-Min Chou.Nijman. Maternal Morbidity And Mortality Associated With Conservative Management For Placenta Morbidly Adherent (Accreta) Diagnosed During Pregnancy. Report Of 15 Cases.
[3].
Chou MM, Ho ES, Lee YH. Prenatal Diagnosis Of Placenta Accreta By Trans Abdominal Colour Doppler Ultrasound. Ultrasound Obstet Gynecol 2000;15(1):28-35.
[4].
Khong TY. The Pathology Of Placenta Accreta: A Worldwide Epidemic. J Clin Pathol 2008;61(2):1243-1246.
[5].
Wu S, Kocherginsky M, Hibbard JU. Abnormal Placentation: 20-Year Analysis. Am J Obstet Gynecol 2005;192(5): 1458-1461.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Background. Non-communicable diseases are responsible for significant disability and death worldwide with developing countries carrying an appreciable burden, imposing a heavy socioeconomic cost on individuals, families, and health systems. The aim of this study was to assess the prevalence of hypertension, diabetes mellitus (DM) and obesity in a semi-urban riverine community in Nigeria. Methods.......
Keywords: Hypertension, Diabetes mellitus, Obesity, Riverine community, Non-communicable diseases, Nigeria
[1].
Gouda, Hebe N, Et Al. Burden Of Non-Communicable Disease In Sub-Saharan Africa, 1990-2017: Results From The Global Burden Of Disease Study 2017. The Lancet Global Health, Volume 7, (10), E1375-1387
[2].
Oso, A. (2023). Non-Communicable Diseases: An Emerging Epidemic In Nigeria. Tropical Journal Of Nephrology, 18(1&2), 31–37
[3].
World Health Organization (2017) Noncommunicable Diseases. Available At:
Http://Www.Who.Int/Mediacentre/Factsheets/Fs355/En/ (Accessed: July 2025)
[4].
Ogungbe, O., Abasilim, C., Huffman, M. D., Ojji, D., & Hypertension Treatment In Nigeria Program Team. (2024). Improving Hypertension Control In Nigeria: Early Policy Implications From The Hypertension Treatment In Nigeria Programme. Global Health Research And Policy, 9(26). Https://Doi.Org/10.1186/S41256-024-00368-9
[5].
Olamoyegun M.A, Alare K, Afolabi S.A Et Al. A Systematic Review And Meta-Analysis Of The Prevalence And Risk Factors Of Type 2 Diabetes Mellitus In Nigeria. Clin Diabetes Endocrinol 10,43(2024). Https://Doi.Org/10.1186/S40842-024-00209-1.
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Uso Da Toxina Botulínica No Tratamento Do Bruxismo Do Sono: Revisão De Literatura (2015–2025). |
| Country | : | |
| Authors | : | xxx |
![]() |
: | 10.9790/0853-2501041321 ![]() |
Abstract: Resumo O bruxismo do sono é um distúrbio caracterizado pela atividade repetitiva dos músculos mastigatórios durante o sono, com potenciais efeitos deletérios sobre a saúde bucal, estruturas orofaciais e qualidade de vida. Frente às limitações de terapias convencionais, como o uso de placas interoclusais e terapias comportamentais, a toxina botulínica......
[1]. AL-WAYLI, Hessa. Treatment Of Chronic Pain Associated With Nocturnal Bruxism With Botulinum Toxin. A Prospective And Randomized Clinical Study. Journal Of Clinical And Experimental Dentistry, V. 9, N. 1, P. E112, 2017.
[2]. BUZATU, Roxana Et Al. Efficacy And Safety Of Botulinum Toxin In The Management Of Temporomandibular Symptoms Associated With Sleep Bruxism: A Systematic Review. Dentistry Journal, V. 12, N. 6, P. 156, 2024.
[3]. CRUSE, Belinda Et Al. Efficacy Of Botulinum Toxin Type A In The Targeted Treatment Of Sleep Bruxism: A Double-Blind, Randomised, Placebo-Controlled, Cross-Over Study. BMJ Neurology Open, V. 4, N. 2, P. E000328, 2022.
[4]. CUNHA, Fernanda Rabelo Et Al. Utilizaçāo Da Toxina Botulínica No Tratamento Do Bruxismo. Research, Society And Development, V. 11, N. 4, P. E34011427304-E34011427304, 2022.
[5]. D'DALARPONIO, Pedro De Alcantara Torquette Et Al. Uso Da Toxina Botulínica No Tratamento Do Bruxismo: Uma Análise Abrangente De Diagnóstico, Tratamento E Suas Correlações Clínicas. Research, Society And Development, V. 12, N. 11, P. E47121143690-E47121143690, 2023
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Background: Mycobacterium ulcerans infection (Buruli ulcer) is a debilitating disease characterized by extensive and severe destruction of the skin and subcutaneous tissue resulting in the formation of large ulcers. This necrotizing neglected tropical disease whose mode of transmission is still unknown was regarded as an emerging infectious disease by WHO in 1998. Index cases of BU were first reported in Ibadan (now in Oyo State), south-west, Nigeria.......
[1].
Oke A.A., Komolafe I.O., Akinwale O.P., Gyang P.V., Henry E. And Nwafor T. (2018). Index Cases Of Buruli Ulcer Disease In Three States Of South-West, Nigeria – A Preliminary Study. IOSR J Pharm Biol Sci, 13(2) Ver. V : 51-56.
[2].
Röltgen K, Pluschke G. Buruli Ulcer: History And Disease Burden. Buruli Ulcer: Mycobacterium Ulcerans Disease. 2019 Apr 30:1-41.
[3].
Guenin-Macé L, Ruf MT, Pluschke G, Demangel C. Mycolactone: More Than Just A Cytotoxin. Buruli Ulcer: Mycobacterium Ulcerans Disease. 2019 Apr 30:117-34.
[4].
Akolgo GA, Asiedu KB, Amewu RK. Exploring Mycolactone—The Unique Causative Toxin Of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker For Diagnosis, And Therapeutic Potential. Toxins. 2024 Dec 6;16(12):528.
[5].
Oluniyi P., Oke A. A., Komolafe I.O. (2017). Presumptive Diagnosis Of Buruli Ulcer Disease Based On Clinical Presentations J. Micro. Infec. Dis. 7(1): 36-34
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Background: Three dimensional root canal filling, an indispensable condition to isolate the root canal system in endodontic therapy, cannot be achieved if the extirpated and prepared canal is not dry before obturation. The absorbent paper points are made of wood fibers, cotton fibers and sodium silicate, with great water absorption and flexibility. Absorbent paper points are used not only to dry root canals after irrigation, but also to carry antiseptic.......
Keywords: Paper point, DiaDent, META, SureEndo
[1].
Wakabayaski H, Masumoto K, Tachibana H, Tuzuki N. A New Instrument For Drying Root Canals. Int Endod J. 1987 Nov;20(6):298-9. Doi: 10.1111/J.1365-2591.1987.Tb00631.X. PMID: 3481792.
[2].
Edwards RO, Bandyopadhyay S. Physical And Mechanical Properties Of Endodontic Absorbent Paper Points. J Endod. 1981 Mar;7(3):123-7. Doi: 10.1016/S0099-2399(81)80126-4. PMID: 6938632.
[3].
Moller B, Hensten-Pettersen A. Biological Evaluation Of Absorbent Paper Points. Int Endod J. 1985 Jul;18(3):183-6. Doi: 10.1111/J.1365-2591.1985.Tb00438.X. PMID: 3861589.
[4].
Silva RG. Capacidades De Absor~Ao Dos Cones De Papel Absorventes De Diferentes Marcas. Sao Paolo Rev Odontol USP 1989;3:354-6.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Résumé La révélation initiale d’un adénocarcinome pulmonaire par une masse sternale est rare et traduit souvent une forme localement avancée. Nous rapportons le cas d’un patient âgé de 43 ans, tabagique chronique à 28 paquets-années sevré, alcoolique chronique et consommateur de cannabis arrêté, ayant un père suivi pour néoplasie pulmonaire, et qui présente depuis 6 mois une tuméfaction sternale associé à des lombalgies droites avec altération.....
[1].
Travis WD Et Al. The 2021 WHO Classification Of Lung Tumors. J Thorac Oncol. 2021;16(3):E1–E14.
[2].
ESMO Guidelines Committee. Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2023.
[3].
Goldstraw P, Et Al. IASLC Staging Manual In Thoracic Oncology: 9th Edition Update. J Thorac Oncol. 2024.
[4].
Radiotherapy For Chest Wall Invasion In Lung Cancer. J Thorac Dis. 2022.
[5].
Immunotherapy For NSCLC: Breakthroughs And Challenges. Lancet Respir Med. 2020..

